WCM
REGN icon

Wedge Capital Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Wedge Capital Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$29.8M Buy
47,775
+8,063
+20% +$5.49M 0.49% 86
2026
Q1 		$30.7M Sell
39,712
-1,590
-4% -$1.22M 0.57% 64
2025
Q4 		$31.9M Sell
41,302
-3,893
-9% -$2.64M 0.57% 69
2025
Q3 		$25.4M Buy
+45,195
New +$25.6M 0.43% 90

Other funds holding REGN

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
GA
GuoLine Advisory Singapore $1.07B AUM 26.27% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
VF
Vest Financial Mclean, Virginia $9.52B AUM 31.6% 1-Year Est. Return
AIP
ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.87B AUM 24.22% 1-Year Est. Return

Wedge Capital Management's REGN Position: Q2 2026 in Review

Wedge Capital Management increased its Regeneron Pharmaceuticals (REGN) stake by 20% in Q2 2026, buying an estimated $5.49M and bringing the position to 47,775 shares worth $29.8M. The position accounts for 0.49% of the portfolio, ranked #86.

Wedge Capital Management first reported a position in REGN in Q3 2025 and has held it in 4 quarters since. The position peaked at $31.9M in Q4 2025. 334 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Wedge Capital Management held 47,775 shares of Regeneron Pharmaceuticals worth $29.8M as of Q2 2026.
  • Wedge Capital Management bought 8,063 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $5.49M.
  • Regeneron Pharmaceuticals made up 0.49% of Wedge Capital Management's portfolio in Q2 2026, its #86 holding.
  • Wedge Capital Management first reported a position in Regeneron Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • Wedge Capital Management's Regeneron Pharmaceuticals position peaked at $31.9M in Q4 2025.
  • 334 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Wedge Capital Management's 13F filing for Q2 2026, filed 10 Jul 2026.